MacroGenics
MGNX
#8651
Rank
C$0.33 B
Marketcap
C$5.22
Share price
-7.73%
Change (1 day)
128.04%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): C-$2.14

According to MacroGenics's latest financial reports the company's current EPS (TTM) is C-$2.16. In 2025 the company made an earnings per share (EPS) of C-$1.66 a decrease over its 2024 EPS that were of C-$1.51.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$2.1428.67%
2025C-$1.6610.28%
2024C-$1.51613.33%
2023C-$0.21-92.31%
2022C-$2.75-42.14%
2021C-$4.7536.44%
2020C-$3.48-21.84%
2019C-$4.46-24.58%
2018C-$5.91675.93%
2017C-$0.76-68.05%
2016C-$2.38168.25%
2015C-$0.89-55%
2014C-$1.973400%
2013C-$0.05641-108.68%
2012C$0.6524.49%
2011C$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.85-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.81-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.42-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.46-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$5.04-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$5.02-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C-$3.23 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA